Cargando…
Double-blind controlled trial of lecithinized superoxide dismutase in patients with idiopathic interstitial pneumonia – short term evaluation of safety and tolerability
BACKGROUND: Idiopathic interstitial pneumonias such as idiopathic pulmonary fibrosis or fibrotic nonspecific interstitial pneumonia are irreversible progressive pulmonary diseases that often have fatal outcomes. Although the etiology of idiopathic interstitial pneumonias is not yet fully understood,...
Autores principales: | Kamio, Koichiro, Azuma, Arata, Ohta, Ken, Sugiyama, Yukihiko, Nukiwa, Toshihiro, Kudoh, Shoji, Mizushima, Tohru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032867/ https://www.ncbi.nlm.nih.gov/pubmed/24886036 http://dx.doi.org/10.1186/1471-2466-14-86 |
Ejemplares similares
-
The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial
por: Taniguchi, Hiroyuki, et al.
Publicado: (2011) -
A lecithinized superoxide dismutase (PC-SOD) improves ulcerative colitis
por: Suzuki, Y, et al.
Publicado: (2008) -
Lecithinized superoxide dismutase in the past and in the present: Any role in the actual pandemia of COVID-19?
por: Farella, Ilaria, et al.
Publicado: (2021) -
Serum surfactant protein D as a predictive biomarker for the efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of the phase 3 trial in Japan
por: Ikeda, Kimiyuki, et al.
Publicado: (2020) -
Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan
por: Ogura, Takashi, et al.
Publicado: (2023)